MedTrace Logo

Effect of Fluvastatin on Top of Clopidogrel and Aspirin in Patients After DES Implantation on Platelet Aggregation

NCT00465322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2007-04-25

No results posted yet for this study

Summary

The purpose of the study was to determine the influence of fluvastatin and atorvastatin on platelet aggregation in patients treated with aspirin and plavix after coronary stenting. We hypothezied a positive effect of fluvastatin on platelet aggregation levels.

Conditions

  • Drug-Interactions

Interventions

DRUG

fluvastatin

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Otto M Hess, Prof. · Cardiology University Hospital Bern

  • Peter Wenaweser, MD · Cardiology University Hospital Bern

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00465322 on ClinicalTrials.gov